NGM
NGM Biopharmaceuticals Inc
Price:  
1.54 
USD
Volume:  
2,350,830.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NGM WACC - Weighted Average Cost of Capital

The WACC of NGM Biopharmaceuticals Inc (NGM) is 6.0%.

The Cost of Equity of NGM Biopharmaceuticals Inc (NGM) is 8.35%.
The Cost of Debt of NGM Biopharmaceuticals Inc (NGM) is 5.00%.

Range Selected
Cost of equity 6.50% - 10.20% 8.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.1% - 6.9% 6.0%
WACC

NGM WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.58 0.95
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 10.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.1% 6.9%
Selected WACC 6.0%